共 50 条
- [24] UGT1A1 polymorphisms in cancer: impact on irinotecan treatment PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2017, 10 : 61 - 68
- [25] Screening of patients with Gilbert's Syndrome from South India identifies UGT1A1*28 as the most predominant mutation in UGT1A1 gene RESEARCH JOURNAL OF BIOTECHNOLOGY, 2018, 13 (04): : 37 - 40
- [27] Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients CANCER SCIENCE, 2007, 98 (09): : 1461 - 1467
- [30] UGT1A1 and UGT1A9 Are Responsible for Phase II Metabolism of Tectorigenin and Irigenin In Vitro MOLECULES, 2022, 27 (13):